Cathryn Hufford Bock

Cathryn Hufford Bock

Auto-generated profile, based on publicly available information

Cathryn Hufford Bock

Wayne State University

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Journal of Urology
Verified
Journal Article
Closed access
IPIsaac J. Powell
Isaac J. Powell
CBCathryn H. Bock
Cathryn H. Bock
JRJulie J. Ruterbusch
Julie J. Ruterbusch
WSWael Sakr
Wael Sakr
The incidence of prostate cancer is approximately 60% higher and the mortality rate is 2 to 3 times greater in black than in white American men. We propose that a more rapid prostate cancer growth rate and/or earlier transformation from latent to aggressive prostate cancer in black than in white men contribute to this disparity. We evaluated entirely embedded prostate glands on autopsy from 1,056 black and white men who died of causes other than prostate cancer. We also reviewed data from our radical prostatectomy database and from the Detroit Surveillance, Epidemiology and End Results database. Autopsy data indicated that subclinical prostate cancer in black and white men starts at early age and clinical characteristics do not differ by race at early ages. Radical prostatectomy specimen data revealed that prostate cancer volume and Gleason grade were greater in black than in white men. Advanced or metastatic prostate cancer occurred at a 4:1 ratio in black and white men, respectively, in the Detroit Surveillance, Epidemiology and End Results registry database. Results showed that age at prostate cancer initiation and clinical characteristics did not differ by race in our autopsy series, prostate cancer volume after radical prostatectomy was greater in black than in white men and disease became distant disease at a ratio of 4 black men to 1 white man in the Detroit Surveillance, Epidemiology and End Results population. These findings support the concept that prostate cancer grows more rapidly in black than in white men and/or earlier transformation from latent to aggressive prostate cancer occurs in black than in white men.

1 July 2009 in Urology
Verified
Journal Article
Closed access
JBJennifer L. Beebe-Dimmer
Jennifer L. Beebe-Dimmer
Nora NockNora Nock
Nora Nock
CNChristine Neslund-Dudas
Christine Neslund-Dudas
ARAndrew Rundle
Andrew Rundle
CBCathryn H. Bock
Cathryn H. Bock
BRBenjamin A. Rybicki
Benjamin A. Rybicki

1 July 2009 in Human Genetics
Verified
Journal Article
Closed access
PDF file
CBCathryn Hufford Bock
Cathryn Hufford Bock
ASAnn G. Schwartz
Ann G. Schwartz
JRJulie J. Ruterbusch
Julie J. Ruterbusch
ALAlbert M. Levin
Albert M. Levin
CNChristine Neslund-Dudas
Christine Neslund-Dudas
BRBenjamin A. Rybicki
Benjamin A. Rybicki

1 April 2005 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
DPDivya A. Patel
Divya A. Patel
CBCathryn H. Bock
Cathryn H. Bock
KSKendra Schwartz
Kendra Schwartz
AWAngela S. Wenzlaff
Angela S. Wenzlaff
RDRaymond Y. Demers
Raymond Y. Demers
RSRichard K. Severson
Richard K. Severson

14 January 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
ZDZhaohui Du
Zhaohui Du
NWNiels Weinhold
Niels Weinhold
GSGregory Chi Song
Gregory Chi Song
KRKristin A. Rand
Kristin A. Rand
DBDavid J. Van Den Berg
David J. Van Den Berg
Wendy CozenWendy Cozen
Wendy Cozen
Persons of African ancestry (AA) have a twofold higher risk for multiple myeloma (MM) compared with persons of European ancestry (EA). Genome-wide association studies (GWASs) support a genetic contribution to MM etiology in individuals of EA. Little is known about genetic risk factors for MM in individuals of AA. We performed a meta-analysis of 2 GWASs of MM in 1813 cases and 8871 controls and conducted an admixture mapping scan to identify risk alleles. We fine-mapped the 23 known susceptibility loci to find markers that could better capture MM risk in individuals of AA and constructed a polygenic risk score (PRS) to assess the aggregated effect of known MM risk alleles. In GWAS meta-analysis, we identified 2 suggestive novel loci located at 9p24.3 and 9p13.1 at P < 1 × 10−6; however, no genome-wide significant association was noted. In admixture mapping, we observed a genome-wide significant inverse association between local AA at 2p24.1-23.1 and MM risk in AA individuals. Of the 23 known EA risk variants, 20 showed directional consistency, and 9 replicated at P < .05 in AA individuals. In 8 regions, we identified markers that better capture MM risk in persons with AA. AA individuals with a PRS in the top 10% had a 1.82-fold (95% confidence interval, 1.56-2.11) increased MM risk compared with those with average risk (25%-75%). The strongest functional association was between the risk allele for variant rs56219066 at 5q15 and lower ELL2 expression (P = 5.1 × 10−12). Our study shows that common genetic variation contributes to MM risk in individuals with AA.

6 September 2007 in The Prostate
Verified
Journal Article
Closed access
PDF file
CNChristine Neslund‐Dudas
Christine Neslund‐Dudas
CBCathryn H. Bock
Cathryn H. Bock
KMKristin Monaghan
Kristin Monaghan
Nora NockNora Nock
Nora Nock
JYJames J. Yang
James J. Yang
BRBenjamin A. Rybicki
Benjamin A. Rybicki